Dallas Oncology Consultants, PA

Duncanville, Texas 75137

0 studies enrolling now · 4 studies all time

What they study most

Breast Adenocarcinoma, Clear Cell Renal Cell Carcinoma, Hormone Receptor Positive, Multiple Myeloma, Non-Small Cell Lung Carcinoma, Stage I Renal Cell Cancer AJCC v6 and v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage II Renal Cell Cancer AJCC v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7, Stage III Renal Cell Cancer AJCC v7

Studies at this site

• Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) — Running, not enrolling
• Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery — Completed
• Trial of Romidepsin and Bortezomib for Multiple Myeloma — Stopped early
• Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lung Cancer — Completed